← Leaderboards
Thomas A Werfel
Vanderbilt University
$1,074,749
Attributed
$1,479,870
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $470.6K · FY2018–24$500K$375K$250K$125K$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,479,870 · 4
By mechanism
P20$754,781 · 1
R21$401,500 · 1
R41$306,556 · 1
F32$17,033 · 1
Top collaborators
- Glenn Madison Walker3 shared
- Katie Heath1 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- Elaine Sanders Bush$14,767,671
- Rebecca Sara Cook$4,266,124
- Md Jashim Uddin$728,003
- Paul J Gresch$136,252
- Benjamin Christian Hacker$78,323
Others in their field
Other Emerging Leaders on “Surface”
- Hanjoon Ryu$28,519,898
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,093,619
- Robert J Woods · Virginia Polytechnic Institute And State University$12,760,318
- Crystal Mackall · Children'S Hosp Of Philadelphia$12,176,453
- Shadi Dayeh · University Of California, San Diego$11,849,859
- Kevin Wiehe · Duke University$11,369,637
Research focus
SurfaceTechnologyPharmaceutical PreparationsDrug KineticsPolymersPreventResearch PersonnelMississippiBaseOrganUniversitiesCharacteristicsCenters Of Research ExcellenceDrug Delivery SystemsResponsePlasmaMonitorAutomobile DrivingAutoimmunityAffinityApoptoticBreast Cancer TreatmentAcetatesClinical Investigation
Grant awards (7)
Microdosing Implant to Mitigate Depression Associated with Opioid Use Disorder$306,556
R41 · FY2024 · EB · contact PI
Macrophage-specific tumor immunotherapy via glycosylated-nanoparticles$251,648
P20 · FY2022 · GM · contact PI
Biodegradable microfuses to enable the safe and compliant long-term interval dosing of 5HT2A agonists$219,000
R21 · FY2022 · EB · contact PI
Macrophage-specific tumor immunotherapy via glycosylated-nanoparticles$251,567
P20 · FY2021 · GM · contact PI
Biodegradable microfuses to enable the safe and compliant long-term interval dosing of 5HT2A agonists$182,500
R21 · FY2021 · EB · contact PI
Macrophage-specific tumor immunotherapy via glycosylated-nanoparticles$251,566
P20 · FY2020 · GM · contact PI
Role of thromboxane/prostaglandin endoperoxide receptor in platelet-assisted breast cancer metastasis$17,033
F32 · FY2018 · CA · contact PI